97 related articles for article (PubMed ID: 22885283)
1. The response of the fibrinolytic system to mycobacteria infection.
Rodríguez-Flores E; Campuzano J; Aguilar D; Hernández-Pando R; Espitia C
Tuberculosis (Edinb); 2012 Nov; 92(6):497-504. PubMed ID: 22885283
[TBL] [Abstract][Full Text] [Related]
2. The fibrinolytic system in dissemination and matrix protein deposition during a mycobacterium infection.
Sato J; Schorey J; Ploplis VA; Haalboom E; Krahule L; Castellino FJ
Am J Pathol; 2003 Aug; 163(2):517-31. PubMed ID: 12875972
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo activities of a new lead compound I2906 against Mycobacterium tuberculosis.
Lu J; Yue J; Wu J; Luo R; Hu Z; Li J; Bai Y; Tang Z; Xian Q; Zhang X; Wang H
Pharmacology; 2010; 85(6):365-71. PubMed ID: 20530976
[TBL] [Abstract][Full Text] [Related]
4. Mucosal immunization with recombinant heparin-binding haemagglutinin adhesin suppresses extrapulmonary dissemination of Mycobacterium bovis bacillus Calmette-Guérin (BCG) in infected mice.
Kohama H; Umemura M; Okamoto Y; Yahagi A; Goga H; Harakuni T; Matsuzaki G; Arakawa T
Vaccine; 2008 Feb; 26(7):924-32. PubMed ID: 18192091
[TBL] [Abstract][Full Text] [Related]
5. Histopathogenesis of experimental Mycobacterium bovis infection in mice.
Chambers MA; Gavier-Widen D; Hewinson RG
Res Vet Sci; 2006 Feb; 80(1):62-70. PubMed ID: 15922378
[TBL] [Abstract][Full Text] [Related]
6. Specific bacterial genotypes of Mycobacterium tuberculosis cause extensive dissemination and brain infection in an experimental model.
Hernandez Pando R; Aguilar D; Cohen I; Guerrero M; Ribon W; Acosta P; Orozco H; Marquina B; Salinas C; Rembao D; Espitia C
Tuberculosis (Edinb); 2010 Jul; 90(4):268-77. PubMed ID: 20580613
[TBL] [Abstract][Full Text] [Related]
7. Role of tumor necrosis factor-alpha in Mycobacterium-induced granuloma formation in tumor necrosis factor-alpha-deficient mice.
Kaneko H; Yamada H; Mizuno S; Udagawa T; Kazumi Y; Sekikawa K; Sugawara I
Lab Invest; 1999 Apr; 79(4):379-86. PubMed ID: 10211990
[TBL] [Abstract][Full Text] [Related]
8. Superior virulence of Mycobacterium bovis over Mycobacterium tuberculosis (Mtb) for Mtb-resistant and Mtb-susceptible mice is manifest as an ability to cause extrapulmonary disease.
Medina E; Ryan L; LaCourse R; North RJ
Tuberculosis (Edinb); 2006 Jan; 86(1):20-7. PubMed ID: 16253563
[TBL] [Abstract][Full Text] [Related]
9. GLS/IL-12-modified Mycobacterium smegmatis as a novel anti-tuberculosis immunotherapeutic vaccine.
Yang C; He YL; Zhang L; Xu L; Yi Z; Wang Y; Li N; Zhu D
Int J Tuberc Lung Dis; 2009 Nov; 13(11):1360-6. PubMed ID: 19861007
[TBL] [Abstract][Full Text] [Related]
10. The thrombomodulin lectin-like domain does not change host responses to tuberculosis.
Kager LM; de Vos AF; Roelofs JJ; van der Loos CM; de Boer OJ; van't Veer C; Conway EM; van der Poll T
Thromb Haemost; 2014 Feb; 111(2):345-53. PubMed ID: 24136651
[TBL] [Abstract][Full Text] [Related]
11. Secretory leukocyte protease inhibitor: a secreted pattern recognition receptor for mycobacteria.
Gomez SA; Argüelles CL; Guerrieri D; Tateosian NL; Amiano NO; Slimovich R; Maffia PC; Abbate E; Musella RM; Garcia VE; Chuluyan HE
Am J Respir Crit Care Med; 2009 Feb; 179(3):247-53. PubMed ID: 19011154
[TBL] [Abstract][Full Text] [Related]
12. Induction of a protective response with an IgA monoclonal antibody against Mycobacterium tuberculosis 16kDa protein in a model of progressive pulmonary infection.
López Y; Yero D; Falero-Diaz G; Olivares N; Sarmiento ME; Sifontes S; Solis RL; Barrios JA; Aguilar D; Hernández-Pando R; Acosta A
Int J Med Microbiol; 2009 Aug; 299(6):447-52. PubMed ID: 19157977
[TBL] [Abstract][Full Text] [Related]
13. Modeling tuberculosis pathogenesis through ex vivo lung tissue infection.
Carranza-Rosales P; Carranza-Torres IE; Guzmán-Delgado NE; Lozano-Garza G; Villarreal-Treviño L; Molina-Torres C; Villarreal JV; Vera-Cabrera L; Castro-Garza J
Tuberculosis (Edinb); 2017 Dec; 107():126-132. PubMed ID: 29050759
[TBL] [Abstract][Full Text] [Related]
14. A new vaccine against tuberculosis shows greater protection in a mouse model with progressive pulmonary tuberculosis.
Castañon-Arreola M; López-Vidal Y; Espitia-Pinzón C; Hernández-Pando R
Tuberculosis (Edinb); 2005; 85(1-2):115-26. PubMed ID: 15687035
[TBL] [Abstract][Full Text] [Related]
15. Effects of morphine during Mycobacterium tuberculosis H37Rv infection in mice.
Singh RP; Jhamb SS; Singh PP
Life Sci; 2008 Jan; 82(5-6):308-14. PubMed ID: 18191418
[TBL] [Abstract][Full Text] [Related]
16. Short report: modulation of Mycobacterium tuberculosis infection by Plasmodium in the murine model.
Scott CP; Kumar N; Bishai WR; Manabe YC
Am J Trop Med Hyg; 2004 Feb; 70(2):144-8. PubMed ID: 14993625
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of immunogenicity and protective efficacy against Mycobacterium tuberculosis infection elicited by recombinant Mycobacterium bovis BCG expressing human Interleukin-12p70 and Early Secretory Antigen Target-6 fusion protein.
Deng Y; Bao L; Yang X
Microbiol Immunol; 2011 Nov; 55(11):798-808. PubMed ID: 21831202
[TBL] [Abstract][Full Text] [Related]
18. Course of murine tuberculosis and response to first-line therapy depends on route of infection and inoculum size.
de Steenwinkel JE; ten Kate MT; de Knegt GJ; Verbrugh HA; van Belkum A; Hernandez-Pando R; Bakker-Woudenberg IA
Int J Tuberc Lung Dis; 2011 Nov; 15(11):1478-84, i. PubMed ID: 22008760
[TBL] [Abstract][Full Text] [Related]
19. Mycobacterium tuberculosis ECF sigma factor sigC is required for lethality in mice and for the conditional expression of a defined gene set.
Sun R; Converse PJ; Ko C; Tyagi S; Morrison NE; Bishai WR
Mol Microbiol; 2004 Apr; 52(1):25-38. PubMed ID: 15049808
[TBL] [Abstract][Full Text] [Related]
20. The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination.
Pethe K; Alonso S; Biet F; Delogu G; Brennan MJ; Locht C; Menozzi FD
Nature; 2001 Jul; 412(6843):190-4. PubMed ID: 11449276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
